GenoLogics has released Geneus 4.0, a new version of its lab and data management system for genomics research. According to a statement, enhancements include the ability to handle next-generation sequencing workflows, advanced querying and reporting capabilities, and a secure web interface to facilitate collaboration.
The solution integrates with instruments and software programs from third-party genomics technology providers, including Illumina, Applied Biosystems, and Roche. Labs can create their own workflows and processes but do not need to write their own code to do so.
Progeniq has launched BioBoost v4.0 Accelerator for Mac OS X
BioBoost is an FPGA-based system that accelerates bioinformatics applications like Smith-Waterman, ClustalW, and HMMer. Researchers can now use BioBoost on Macs to run these algorithms more than 50 times faster than current CPUs, according to the company.
BioBoost v4.0 is available for demo upon request, the company said.
Rosetta Biosoftware has released Syllego System Version 2.0, which integrates microarray data, sequencing data, and clinical information.
Rosetta said that the software allows users to work with non-standardized study data from multiple platforms, access and implement the most appropriate analysis method, and share and publish data as part of a collaboration.
Version 2.0 has an expanded set of data analysis tools and the option to use server-side processing.
Simulations Plus has released version 4.5 of its ClassPharmer software for analyzing chemical libraries and designing new molecular structures.
According to the company, the update to ClassPharmer allows pharmaceutical research chemists to design new drug molecules faster and select promising candidates from a large number of possible molecular structures.
ClassPharmer lets chemists view relationships between the real structures and their measured properties, and to use that data for in silico design. The tool is integrated with the firm’s ADMET Predictor software, allowing a scientist to assess whether the molecules are likely to have desirable properties, according to the company.
One new feature of the software is Pair SARs, referring to structure-activity relationships. The Pair SAR feature identifies similar pairs of molecules that differ in their activities, allowing researchers to know the implications of the changes to the molecule they might make.
CLC bio has released CLC Genomics Workbench 1.0, which can analyze and visualize data from all the major second-generation sequencing platforms.
In benchmark tests, CLC bio said it used the software to assemble half a million 454 reads against the full E. coli reference genome in around 2 minutes on a dual-core computer with 1 gigabyte of RAM.
This acceleration is based on integrated SIMD high-performance computing technology, and can increase further when more CPU cores and RAM are available, the company said.
CLC said it expects to release a benchmark white paper in the near future.
CLC Genomics Workbench 1.0 takes advantage of paired-end data, and supports a number of features, such as reference assembly of genomes, de novo assembly of genomes, SNP detection using advanced models, multiplexing, and high-throughput trimming.
Release 95 of the European Molecular Biology Laboratory Nucleotide Sequence Database is available from the European Bioinformatics Institute’s ftp server and other verified mirror sites.
The Release 95 files total 105 GB compressed and 588 GB uncompressed.
Whatman, part of GE Healthcare, and VigeneTech have launched a customized version of the MicroVigene spot-finding software package that is tailored to Whatman FAST Quant(R) samples. The software provides image quantification and automation for FAST Quant(R) protein array image and data analysis, the firms said in a statement.
According to a statement, the new software will allow FAST Quant(R) users to rapidly and more accurately analyze fluorescent immunoassay results from multiplexed platforms. More accurate spot finding in an array format assures increased accuracy of assay results, the companies said.
Iris BioTechnologies, a theranostics company, has launched its proprietary database, BioWindows.
According to the company, BioWindows is designed for individuals to compile personalized in-depth profiles. This survey, along with a tissue biopsy, can be used by medical professionals to accurately assess the most optimal form of treatment. The database compares a patient’s genetic cata to a central repository of gene profiles to assist doctors and scientists when they make their clinical decisions about individual patients.